Table of Contents

June 15, 2022; Volume 19,Issue 6

C

  1. Cao, Yandong

    1. The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families
      Li Dong, Hailian Zhang, Huan Zhang, Yingnan Ye, Yanan Cheng, Lijuan Li, Lijuan Wei, Lei Han, Yandong Cao, Shixia Li, Xishan Hao, Juntian Liu and Jinpu Yu
      Cancer Biology & Medicine June 2022, 19 (6) 850-870; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0011

  2. Chai, Junyue

    1. Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China
      Chunli Zhang, Wei Wan, Shuai Zhang, Jingwen Wang, Ru Feng, Jiangtao Li, Junyue Chai, Hebing Zhou, Liru Wang, Yuping Zhong, Xiaodong Mo, Mengzhu Shen, Hongmei Jing and Hui Liu
      Cancer Biology & Medicine June 2022, 19 (6) 871-883; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0474

  3. Chen, Haizhu

    1. Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP
      Yan Qin, Haizhu Chen, Peng Liu, Changgong Zhang, Jianliang Yang, Lin Gui, Xiaohui He, Liqiang Zhou, Shengyu Zhou, Shiyu Jiang, Hongxin Jiang and Yuankai Shi
      Cancer Biology & Medicine June 2022, 19 (6) 893-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0193

  4. Chen, Kexin

    1. The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
      Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent and Jilong Yang
      Cancer Biology & Medicine June 2022, 19 (6) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0270

  5. Cheng, Jiamin

    1. The advanced development of molecular targeted therapy for hepatocellular carcinoma
      Tao Yan, Lingxiang Yu, Ning Zhang, Caiyun Peng, Guodong Su, Yi Jing, Linzhi Zhang, Tong Wu, Jiamin Cheng, Qian Guo, Xiaoliang Shi and Yinying Lu
      Cancer Biology & Medicine June 2022, 19 (6) 802-817; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0661

  6. Cheng, Yanan

    1. The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families
      Li Dong, Hailian Zhang, Huan Zhang, Yingnan Ye, Yanan Cheng, Lijuan Li, Lijuan Wei, Lei Han, Yandong Cao, Shixia Li, Xishan Hao, Juntian Liu and Jinpu Yu
      Cancer Biology & Medicine June 2022, 19 (6) 850-870; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0011

D

  1. Dong, Li

    1. The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families
      Li Dong, Hailian Zhang, Huan Zhang, Yingnan Ye, Yanan Cheng, Lijuan Li, Lijuan Wei, Lei Han, Yandong Cao, Shixia Li, Xishan Hao, Juntian Liu and Jinpu Yu
      Cancer Biology & Medicine June 2022, 19 (6) 850-870; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0011

  2. Dong, Yang

    1. Microsurgery vs. radiosurgery for the treatment of multiple metastases in the brain: a retrospective cohort study
      Qun Liu, Qiang Yin, Yang Dong, Fengtong Li, Wenliang Li and Xiaoguang Wang
      Cancer Biology & Medicine June 2022, 19 (6) 884-892; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0598

F

  1. Feng, Ru

    1. Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China
      Chunli Zhang, Wei Wan, Shuai Zhang, Jingwen Wang, Ru Feng, Jiangtao Li, Junyue Chai, Hebing Zhou, Liru Wang, Yuping Zhong, Xiaodong Mo, Mengzhu Shen, Hongmei Jing and Hui Liu
      Cancer Biology & Medicine June 2022, 19 (6) 871-883; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0474

G

  1. Ge, Shuang

    1. EHMT2 (G9a) activation in mantle cell lymphoma and its associated DNA methylation and gene expression
      Jun Wang, Hui Xu, Shuang Ge, Chaoshuai Xue, Hailing Li, Xiaotong Jing, Ke Liang, Xiaoying Zhang and Cuijuan Zhang
      Cancer Biology & Medicine June 2022, 19 (6) 836-849; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0371

  2. Gui, Lin

    1. Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP
      Yan Qin, Haizhu Chen, Peng Liu, Changgong Zhang, Jianliang Yang, Lin Gui, Xiaohui He, Liqiang Zhou, Shengyu Zhou, Shiyu Jiang, Hongxin Jiang and Yuankai Shi
      Cancer Biology & Medicine June 2022, 19 (6) 893-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0193

  3. Guo, Qian

    1. The advanced development of molecular targeted therapy for hepatocellular carcinoma
      Tao Yan, Lingxiang Yu, Ning Zhang, Caiyun Peng, Guodong Su, Yi Jing, Linzhi Zhang, Tong Wu, Jiamin Cheng, Qian Guo, Xiaoliang Shi and Yinying Lu
      Cancer Biology & Medicine June 2022, 19 (6) 802-817; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0661

H

  1. Han, Lei

    1. The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families
      Li Dong, Hailian Zhang, Huan Zhang, Yingnan Ye, Yanan Cheng, Lijuan Li, Lijuan Wei, Lei Han, Yandong Cao, Shixia Li, Xishan Hao, Juntian Liu and Jinpu Yu
      Cancer Biology & Medicine June 2022, 19 (6) 850-870; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0011

  2. Hao, Xishan

    1. The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families
      Li Dong, Hailian Zhang, Huan Zhang, Yingnan Ye, Yanan Cheng, Lijuan Li, Lijuan Wei, Lei Han, Yandong Cao, Shixia Li, Xishan Hao, Juntian Liu and Jinpu Yu
      Cancer Biology & Medicine June 2022, 19 (6) 850-870; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0011

  3. He, Xiaohui

    1. Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP
      Yan Qin, Haizhu Chen, Peng Liu, Changgong Zhang, Jianliang Yang, Lin Gui, Xiaohui He, Liqiang Zhou, Shengyu Zhou, Shiyu Jiang, Hongxin Jiang and Yuankai Shi
      Cancer Biology & Medicine June 2022, 19 (6) 893-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0193

  4. Hu, Gaoyong

    1. Anti-tumor pharmacology of natural products targeting mitosis
      Manru Huang, Caiyan Liu, Yingying Shao, Shiyue Zhou, Gaoyong Hu, Shuangshuang Yin, Weiling Pu and Haiyang Yu
      Cancer Biology & Medicine June 2022, 19 (6) 774-801; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0006

  5. Hu, Wei

    1. MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis
      Fengqi Yan, Qinhao Wang, Mingyuan Xia, Yi Ru, Wei Hu, Guang Yan, Xin Xiong, Mei Zhang, Jiancai Wang, Qi Li, Bo Zhang, He Wang, Wei Lin, Guojun Wu and Xia Li
      Cancer Biology & Medicine June 2022, 19 (6) 818-835; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0296

  6. Huang, Manru

    1. Anti-tumor pharmacology of natural products targeting mitosis
      Manru Huang, Caiyan Liu, Yingying Shao, Shiyue Zhou, Gaoyong Hu, Shuangshuang Yin, Weiling Pu and Haiyang Yu
      Cancer Biology & Medicine June 2022, 19 (6) 774-801; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0006

I

  1. Im, Jung Ho

    1. Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04)
      Sung Uk Lee, Jinsil Seong, Tae Hyun Kim, Jung Ho Im, Woo Chul Kim, Kyubo Kim, Hae Jin Park, Tae Gyu Kim, Youngkyong Kim, Bae Kwon Jeong, Jin Hee Kim, Byoung Hyuck Kim and Taek-Keun Nam
      Cancer Biology & Medicine June 2022, 19 (6) 931-944; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0667

J

  1. Jeong, Bae Kwon

    1. Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04)
      Sung Uk Lee, Jinsil Seong, Tae Hyun Kim, Jung Ho Im, Woo Chul Kim, Kyubo Kim, Hae Jin Park, Tae Gyu Kim, Youngkyong Kim, Bae Kwon Jeong, Jin Hee Kim, Byoung Hyuck Kim and Taek-Keun Nam
      Cancer Biology & Medicine June 2022, 19 (6) 931-944; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0667

  2. Jiang, Hongxin

    1. Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP
      Yan Qin, Haizhu Chen, Peng Liu, Changgong Zhang, Jianliang Yang, Lin Gui, Xiaohui He, Liqiang Zhou, Shengyu Zhou, Shiyu Jiang, Hongxin Jiang and Yuankai Shi
      Cancer Biology & Medicine June 2022, 19 (6) 893-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0193

  3. Jiang, Shiyu

    1. Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP
      Yan Qin, Haizhu Chen, Peng Liu, Changgong Zhang, Jianliang Yang, Lin Gui, Xiaohui He, Liqiang Zhou, Shengyu Zhou, Shiyu Jiang, Hongxin Jiang and Yuankai Shi
      Cancer Biology & Medicine June 2022, 19 (6) 893-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0193

  4. Jiang, Zefei

    1. Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines in 2022: stratification and classification
      Jianbin Li and Zefei Jiang
      Cancer Biology & Medicine June 2022, 19 (6) 769-773; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0277

  5. Jing, Hongmei

    1. Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China
      Chunli Zhang, Wei Wan, Shuai Zhang, Jingwen Wang, Ru Feng, Jiangtao Li, Junyue Chai, Hebing Zhou, Liru Wang, Yuping Zhong, Xiaodong Mo, Mengzhu Shen, Hongmei Jing and Hui Liu
      Cancer Biology & Medicine June 2022, 19 (6) 871-883; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0474

  6. Jing, Xiaotong

    1. EHMT2 (G9a) activation in mantle cell lymphoma and its associated DNA methylation and gene expression
      Jun Wang, Hui Xu, Shuang Ge, Chaoshuai Xue, Hailing Li, Xiaotong Jing, Ke Liang, Xiaoying Zhang and Cuijuan Zhang
      Cancer Biology & Medicine June 2022, 19 (6) 836-849; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0371

  7. Jing, Yi

    1. The advanced development of molecular targeted therapy for hepatocellular carcinoma
      Tao Yan, Lingxiang Yu, Ning Zhang, Caiyun Peng, Guodong Su, Yi Jing, Linzhi Zhang, Tong Wu, Jiamin Cheng, Qian Guo, Xiaoliang Shi and Yinying Lu
      Cancer Biology & Medicine June 2022, 19 (6) 802-817; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0661

K

  1. Kim, Byoung Hyuck

    1. Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04)
      Sung Uk Lee, Jinsil Seong, Tae Hyun Kim, Jung Ho Im, Woo Chul Kim, Kyubo Kim, Hae Jin Park, Tae Gyu Kim, Youngkyong Kim, Bae Kwon Jeong, Jin Hee Kim, Byoung Hyuck Kim and Taek-Keun Nam
      Cancer Biology & Medicine June 2022, 19 (6) 931-944; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0667

  2. Kim, Jin Hee

    1. Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04)
      Sung Uk Lee, Jinsil Seong, Tae Hyun Kim, Jung Ho Im, Woo Chul Kim, Kyubo Kim, Hae Jin Park, Tae Gyu Kim, Youngkyong Kim, Bae Kwon Jeong, Jin Hee Kim, Byoung Hyuck Kim and Taek-Keun Nam
      Cancer Biology & Medicine June 2022, 19 (6) 931-944; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0667

  3. Kim, Kyubo

    1. Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04)
      Sung Uk Lee, Jinsil Seong, Tae Hyun Kim, Jung Ho Im, Woo Chul Kim, Kyubo Kim, Hae Jin Park, Tae Gyu Kim, Youngkyong Kim, Bae Kwon Jeong, Jin Hee Kim, Byoung Hyuck Kim and Taek-Keun Nam
      Cancer Biology & Medicine June 2022, 19 (6) 931-944; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0667

  4. Kim, Tae Gyu

    1. Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04)
      Sung Uk Lee, Jinsil Seong, Tae Hyun Kim, Jung Ho Im, Woo Chul Kim, Kyubo Kim, Hae Jin Park, Tae Gyu Kim, Youngkyong Kim, Bae Kwon Jeong, Jin Hee Kim, Byoung Hyuck Kim and Taek-Keun Nam
      Cancer Biology & Medicine June 2022, 19 (6) 931-944; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0667

  5. Kim, Tae Hyun

    1. Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04)
      Sung Uk Lee, Jinsil Seong, Tae Hyun Kim, Jung Ho Im, Woo Chul Kim, Kyubo Kim, Hae Jin Park, Tae Gyu Kim, Youngkyong Kim, Bae Kwon Jeong, Jin Hee Kim, Byoung Hyuck Kim and Taek-Keun Nam
      Cancer Biology & Medicine June 2022, 19 (6) 931-944; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0667

  6. Kim, Woo Chul

    1. Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04)
      Sung Uk Lee, Jinsil Seong, Tae Hyun Kim, Jung Ho Im, Woo Chul Kim, Kyubo Kim, Hae Jin Park, Tae Gyu Kim, Youngkyong Kim, Bae Kwon Jeong, Jin Hee Kim, Byoung Hyuck Kim and Taek-Keun Nam
      Cancer Biology & Medicine June 2022, 19 (6) 931-944; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0667

  7. Kim, Youngkyong

    1. Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04)
      Sung Uk Lee, Jinsil Seong, Tae Hyun Kim, Jung Ho Im, Woo Chul Kim, Kyubo Kim, Hae Jin Park, Tae Gyu Kim, Youngkyong Kim, Bae Kwon Jeong, Jin Hee Kim, Byoung Hyuck Kim and Taek-Keun Nam
      Cancer Biology & Medicine June 2022, 19 (6) 931-944; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0667

L

  1. Lee, Sung Uk

    1. Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04)
      Sung Uk Lee, Jinsil Seong, Tae Hyun Kim, Jung Ho Im, Woo Chul Kim, Kyubo Kim, Hae Jin Park, Tae Gyu Kim, Youngkyong Kim, Bae Kwon Jeong, Jin Hee Kim, Byoung Hyuck Kim and Taek-Keun Nam
      Cancer Biology & Medicine June 2022, 19 (6) 931-944; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0667

  2. Li, Fengtong

    1. Microsurgery vs. radiosurgery for the treatment of multiple metastases in the brain: a retrospective cohort study
      Qun Liu, Qiang Yin, Yang Dong, Fengtong Li, Wenliang Li and Xiaoguang Wang
      Cancer Biology & Medicine June 2022, 19 (6) 884-892; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0598

  3. Li, Hailing

    1. EHMT2 (G9a) activation in mantle cell lymphoma and its associated DNA methylation and gene expression
      Jun Wang, Hui Xu, Shuang Ge, Chaoshuai Xue, Hailing Li, Xiaotong Jing, Ke Liang, Xiaoying Zhang and Cuijuan Zhang
      Cancer Biology & Medicine June 2022, 19 (6) 836-849; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0371

  4. Li, Jianbin

    1. Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines in 2022: stratification and classification
      Jianbin Li and Zefei Jiang
      Cancer Biology & Medicine June 2022, 19 (6) 769-773; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0277

  5. Li, Jiangtao

    1. Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China
      Chunli Zhang, Wei Wan, Shuai Zhang, Jingwen Wang, Ru Feng, Jiangtao Li, Junyue Chai, Hebing Zhou, Liru Wang, Yuping Zhong, Xiaodong Mo, Mengzhu Shen, Hongmei Jing and Hui Liu
      Cancer Biology & Medicine June 2022, 19 (6) 871-883; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0474

  6. Li, Lijuan

    1. The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families
      Li Dong, Hailian Zhang, Huan Zhang, Yingnan Ye, Yanan Cheng, Lijuan Li, Lijuan Wei, Lei Han, Yandong Cao, Shixia Li, Xishan Hao, Juntian Liu and Jinpu Yu
      Cancer Biology & Medicine June 2022, 19 (6) 850-870; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0011

  7. Li, Qi

    1. MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis
      Fengqi Yan, Qinhao Wang, Mingyuan Xia, Yi Ru, Wei Hu, Guang Yan, Xin Xiong, Mei Zhang, Jiancai Wang, Qi Li, Bo Zhang, He Wang, Wei Lin, Guojun Wu and Xia Li
      Cancer Biology & Medicine June 2022, 19 (6) 818-835; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0296

  8. Li, Shixia

    1. The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families
      Li Dong, Hailian Zhang, Huan Zhang, Yingnan Ye, Yanan Cheng, Lijuan Li, Lijuan Wei, Lei Han, Yandong Cao, Shixia Li, Xishan Hao, Juntian Liu and Jinpu Yu
      Cancer Biology & Medicine June 2022, 19 (6) 850-870; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0011

  9. Li, Ting

    1. The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
      Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent and Jilong Yang
      Cancer Biology & Medicine June 2022, 19 (6) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0270

  10. Li, Wenliang

    1. Microsurgery vs. radiosurgery for the treatment of multiple metastases in the brain: a retrospective cohort study
      Qun Liu, Qiang Yin, Yang Dong, Fengtong Li, Wenliang Li and Xiaoguang Wang
      Cancer Biology & Medicine June 2022, 19 (6) 884-892; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0598

  11. Li, Xia

    1. MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis
      Fengqi Yan, Qinhao Wang, Mingyuan Xia, Yi Ru, Wei Hu, Guang Yan, Xin Xiong, Mei Zhang, Jiancai Wang, Qi Li, Bo Zhang, He Wang, Wei Lin, Guojun Wu and Xia Li
      Cancer Biology & Medicine June 2022, 19 (6) 818-835; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0296

  12. Li, Xiangchun

    1. The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
      Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent and Jilong Yang
      Cancer Biology & Medicine June 2022, 19 (6) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0270

  13. Liang, Ke

    1. EHMT2 (G9a) activation in mantle cell lymphoma and its associated DNA methylation and gene expression
      Jun Wang, Hui Xu, Shuang Ge, Chaoshuai Xue, Hailing Li, Xiaotong Jing, Ke Liang, Xiaoying Zhang and Cuijuan Zhang
      Cancer Biology & Medicine June 2022, 19 (6) 836-849; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0371

  14. Liao, Zhichao

    1. The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
      Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent and Jilong Yang
      Cancer Biology & Medicine June 2022, 19 (6) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0270

  15. Lin, Wei

    1. MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis
      Fengqi Yan, Qinhao Wang, Mingyuan Xia, Yi Ru, Wei Hu, Guang Yan, Xin Xiong, Mei Zhang, Jiancai Wang, Qi Li, Bo Zhang, He Wang, Wei Lin, Guojun Wu and Xia Li
      Cancer Biology & Medicine June 2022, 19 (6) 818-835; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0296

  16. Liu, Caiyan

    1. Anti-tumor pharmacology of natural products targeting mitosis
      Manru Huang, Caiyan Liu, Yingying Shao, Shiyue Zhou, Gaoyong Hu, Shuangshuang Yin, Weiling Pu and Haiyang Yu
      Cancer Biology & Medicine June 2022, 19 (6) 774-801; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0006

  17. Liu, Hui

    1. Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China
      Chunli Zhang, Wei Wan, Shuai Zhang, Jingwen Wang, Ru Feng, Jiangtao Li, Junyue Chai, Hebing Zhou, Liru Wang, Yuping Zhong, Xiaodong Mo, Mengzhu Shen, Hongmei Jing and Hui Liu
      Cancer Biology & Medicine June 2022, 19 (6) 871-883; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0474

  18. Liu, Juntian

    1. The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families
      Li Dong, Hailian Zhang, Huan Zhang, Yingnan Ye, Yanan Cheng, Lijuan Li, Lijuan Wei, Lei Han, Yandong Cao, Shixia Li, Xishan Hao, Juntian Liu and Jinpu Yu
      Cancer Biology & Medicine June 2022, 19 (6) 850-870; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0011

  19. Liu, Peng

    1. Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP
      Yan Qin, Haizhu Chen, Peng Liu, Changgong Zhang, Jianliang Yang, Lin Gui, Xiaohui He, Liqiang Zhou, Shengyu Zhou, Shiyu Jiang, Hongxin Jiang and Yuankai Shi
      Cancer Biology & Medicine June 2022, 19 (6) 893-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0193

  20. Liu, Qun

    1. Microsurgery vs. radiosurgery for the treatment of multiple metastases in the brain: a retrospective cohort study
      Qun Liu, Qiang Yin, Yang Dong, Fengtong Li, Wenliang Li and Xiaoguang Wang
      Cancer Biology & Medicine June 2022, 19 (6) 884-892; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0598

  21. Lu, Jia

    1. The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
      Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent and Jilong Yang
      Cancer Biology & Medicine June 2022, 19 (6) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0270

  22. Lu, Yinying

    1. The advanced development of molecular targeted therapy for hepatocellular carcinoma
      Tao Yan, Lingxiang Yu, Ning Zhang, Caiyun Peng, Guodong Su, Yi Jing, Linzhi Zhang, Tong Wu, Jiamin Cheng, Qian Guo, Xiaoliang Shi and Yinying Lu
      Cancer Biology & Medicine June 2022, 19 (6) 802-817; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0661

M

  1. Mo, Xiaodong

    1. Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China
      Chunli Zhang, Wei Wan, Shuai Zhang, Jingwen Wang, Ru Feng, Jiangtao Li, Junyue Chai, Hebing Zhou, Liru Wang, Yuping Zhong, Xiaodong Mo, Mengzhu Shen, Hongmei Jing and Hui Liu
      Cancer Biology & Medicine June 2022, 19 (6) 871-883; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0474

N

  1. Nam, Taek-Keun

    1. Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04)
      Sung Uk Lee, Jinsil Seong, Tae Hyun Kim, Jung Ho Im, Woo Chul Kim, Kyubo Kim, Hae Jin Park, Tae Gyu Kim, Youngkyong Kim, Bae Kwon Jeong, Jin Hee Kim, Byoung Hyuck Kim and Taek-Keun Nam
      Cancer Biology & Medicine June 2022, 19 (6) 931-944; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0667

P

  1. Park, Hae Jin

    1. Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04)
      Sung Uk Lee, Jinsil Seong, Tae Hyun Kim, Jung Ho Im, Woo Chul Kim, Kyubo Kim, Hae Jin Park, Tae Gyu Kim, Youngkyong Kim, Bae Kwon Jeong, Jin Hee Kim, Byoung Hyuck Kim and Taek-Keun Nam
      Cancer Biology & Medicine June 2022, 19 (6) 931-944; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0667

  2. Peng, Caiyun

    1. The advanced development of molecular targeted therapy for hepatocellular carcinoma
      Tao Yan, Lingxiang Yu, Ning Zhang, Caiyun Peng, Guodong Su, Yi Jing, Linzhi Zhang, Tong Wu, Jiamin Cheng, Qian Guo, Xiaoliang Shi and Yinying Lu
      Cancer Biology & Medicine June 2022, 19 (6) 802-817; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0661

  3. Pu, Weiling

    1. Anti-tumor pharmacology of natural products targeting mitosis
      Manru Huang, Caiyan Liu, Yingying Shao, Shiyue Zhou, Gaoyong Hu, Shuangshuang Yin, Weiling Pu and Haiyang Yu
      Cancer Biology & Medicine June 2022, 19 (6) 774-801; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0006

Q

  1. Qin, Yan

    1. Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP
      Yan Qin, Haizhu Chen, Peng Liu, Changgong Zhang, Jianliang Yang, Lin Gui, Xiaohui He, Liqiang Zhou, Shengyu Zhou, Shiyu Jiang, Hongxin Jiang and Yuankai Shi
      Cancer Biology & Medicine June 2022, 19 (6) 893-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0193

R

  1. Ren, Zhiwu

    1. The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
      Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent and Jilong Yang
      Cancer Biology & Medicine June 2022, 19 (6) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0270

  2. Ru, Yi

    1. MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis
      Fengqi Yan, Qinhao Wang, Mingyuan Xia, Yi Ru, Wei Hu, Guang Yan, Xin Xiong, Mei Zhang, Jiancai Wang, Qi Li, Bo Zhang, He Wang, Wei Lin, Guojun Wu and Xia Li
      Cancer Biology & Medicine June 2022, 19 (6) 818-835; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0296

S

  1. Seong, Jinsil

    1. Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04)
      Sung Uk Lee, Jinsil Seong, Tae Hyun Kim, Jung Ho Im, Woo Chul Kim, Kyubo Kim, Hae Jin Park, Tae Gyu Kim, Youngkyong Kim, Bae Kwon Jeong, Jin Hee Kim, Byoung Hyuck Kim and Taek-Keun Nam
      Cancer Biology & Medicine June 2022, 19 (6) 931-944; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0667

  2. Shao, Yingying

    1. Anti-tumor pharmacology of natural products targeting mitosis
      Manru Huang, Caiyan Liu, Yingying Shao, Shiyue Zhou, Gaoyong Hu, Shuangshuang Yin, Weiling Pu and Haiyang Yu
      Cancer Biology & Medicine June 2022, 19 (6) 774-801; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0006

  3. Shen, Mengzhu

    1. Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China
      Chunli Zhang, Wei Wan, Shuai Zhang, Jingwen Wang, Ru Feng, Jiangtao Li, Junyue Chai, Hebing Zhou, Liru Wang, Yuping Zhong, Xiaodong Mo, Mengzhu Shen, Hongmei Jing and Hui Liu
      Cancer Biology & Medicine June 2022, 19 (6) 871-883; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0474

  4. Shi, Xiaoliang

    1. The advanced development of molecular targeted therapy for hepatocellular carcinoma
      Tao Yan, Lingxiang Yu, Ning Zhang, Caiyun Peng, Guodong Su, Yi Jing, Linzhi Zhang, Tong Wu, Jiamin Cheng, Qian Guo, Xiaoliang Shi and Yinying Lu
      Cancer Biology & Medicine June 2022, 19 (6) 802-817; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0661

  5. Shi, Yuankai

    1. Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP
      Yan Qin, Haizhu Chen, Peng Liu, Changgong Zhang, Jianliang Yang, Lin Gui, Xiaohui He, Liqiang Zhou, Shengyu Zhou, Shiyu Jiang, Hongxin Jiang and Yuankai Shi
      Cancer Biology & Medicine June 2022, 19 (6) 893-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0193

  6. Su, Guodong

    1. The advanced development of molecular targeted therapy for hepatocellular carcinoma
      Tao Yan, Lingxiang Yu, Ning Zhang, Caiyun Peng, Guodong Su, Yi Jing, Linzhi Zhang, Tong Wu, Jiamin Cheng, Qian Guo, Xiaoliang Shi and Yinying Lu
      Cancer Biology & Medicine June 2022, 19 (6) 802-817; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0661

T

  1. Teng, Sheng

    1. The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
      Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent and Jilong Yang
      Cancer Biology & Medicine June 2022, 19 (6) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0270

  2. Trent, Jonathan

    1. The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
      Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent and Jilong Yang
      Cancer Biology & Medicine June 2022, 19 (6) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0270

W

  1. Wan, Wei

    1. Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China
      Chunli Zhang, Wei Wan, Shuai Zhang, Jingwen Wang, Ru Feng, Jiangtao Li, Junyue Chai, Hebing Zhou, Liru Wang, Yuping Zhong, Xiaodong Mo, Mengzhu Shen, Hongmei Jing and Hui Liu
      Cancer Biology & Medicine June 2022, 19 (6) 871-883; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0474

  2. Wang, He

    1. MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis
      Fengqi Yan, Qinhao Wang, Mingyuan Xia, Yi Ru, Wei Hu, Guang Yan, Xin Xiong, Mei Zhang, Jiancai Wang, Qi Li, Bo Zhang, He Wang, Wei Lin, Guojun Wu and Xia Li
      Cancer Biology & Medicine June 2022, 19 (6) 818-835; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0296

  3. Wang, Jiancai

    1. MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis
      Fengqi Yan, Qinhao Wang, Mingyuan Xia, Yi Ru, Wei Hu, Guang Yan, Xin Xiong, Mei Zhang, Jiancai Wang, Qi Li, Bo Zhang, He Wang, Wei Lin, Guojun Wu and Xia Li
      Cancer Biology & Medicine June 2022, 19 (6) 818-835; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0296

  4. Wang, Jingwen

    1. Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China
      Chunli Zhang, Wei Wan, Shuai Zhang, Jingwen Wang, Ru Feng, Jiangtao Li, Junyue Chai, Hebing Zhou, Liru Wang, Yuping Zhong, Xiaodong Mo, Mengzhu Shen, Hongmei Jing and Hui Liu
      Cancer Biology & Medicine June 2022, 19 (6) 871-883; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0474

  5. Wang, Jun

    1. EHMT2 (G9a) activation in mantle cell lymphoma and its associated DNA methylation and gene expression
      Jun Wang, Hui Xu, Shuang Ge, Chaoshuai Xue, Hailing Li, Xiaotong Jing, Ke Liang, Xiaoying Zhang and Cuijuan Zhang
      Cancer Biology & Medicine June 2022, 19 (6) 836-849; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0371

  6. Wang, Liru

    1. Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China
      Chunli Zhang, Wei Wan, Shuai Zhang, Jingwen Wang, Ru Feng, Jiangtao Li, Junyue Chai, Hebing Zhou, Liru Wang, Yuping Zhong, Xiaodong Mo, Mengzhu Shen, Hongmei Jing and Hui Liu
      Cancer Biology & Medicine June 2022, 19 (6) 871-883; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0474

  7. Wang, Qinhao

    1. MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis
      Fengqi Yan, Qinhao Wang, Mingyuan Xia, Yi Ru, Wei Hu, Guang Yan, Xin Xiong, Mei Zhang, Jiancai Wang, Qi Li, Bo Zhang, He Wang, Wei Lin, Guojun Wu and Xia Li
      Cancer Biology & Medicine June 2022, 19 (6) 818-835; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0296

  8. Wang, Xiaoguang

    1. Microsurgery vs. radiosurgery for the treatment of multiple metastases in the brain: a retrospective cohort study
      Qun Liu, Qiang Yin, Yang Dong, Fengtong Li, Wenliang Li and Xiaoguang Wang
      Cancer Biology & Medicine June 2022, 19 (6) 884-892; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0598

  9. Wei, Lijuan

    1. The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families
      Li Dong, Hailian Zhang, Huan Zhang, Yingnan Ye, Yanan Cheng, Lijuan Li, Lijuan Wei, Lei Han, Yandong Cao, Shixia Li, Xishan Hao, Juntian Liu and Jinpu Yu
      Cancer Biology & Medicine June 2022, 19 (6) 850-870; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0011

  10. Wu, Guojun

    1. MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis
      Fengqi Yan, Qinhao Wang, Mingyuan Xia, Yi Ru, Wei Hu, Guang Yan, Xin Xiong, Mei Zhang, Jiancai Wang, Qi Li, Bo Zhang, He Wang, Wei Lin, Guojun Wu and Xia Li
      Cancer Biology & Medicine June 2022, 19 (6) 818-835; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0296

  11. Wu, Haixiao

    1. The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
      Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent and Jilong Yang
      Cancer Biology & Medicine June 2022, 19 (6) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0270

  12. Wu, Tong

    1. The advanced development of molecular targeted therapy for hepatocellular carcinoma
      Tao Yan, Lingxiang Yu, Ning Zhang, Caiyun Peng, Guodong Su, Yi Jing, Linzhi Zhang, Tong Wu, Jiamin Cheng, Qian Guo, Xiaoliang Shi and Yinying Lu
      Cancer Biology & Medicine June 2022, 19 (6) 802-817; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0661

X

  1. Xia, Mingyuan

    1. MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis
      Fengqi Yan, Qinhao Wang, Mingyuan Xia, Yi Ru, Wei Hu, Guang Yan, Xin Xiong, Mei Zhang, Jiancai Wang, Qi Li, Bo Zhang, He Wang, Wei Lin, Guojun Wu and Xia Li
      Cancer Biology & Medicine June 2022, 19 (6) 818-835; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0296

  2. Xing, Ruwei

    1. The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
      Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent and Jilong Yang
      Cancer Biology & Medicine June 2022, 19 (6) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0270

  3. Xiong, Xin

    1. MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis
      Fengqi Yan, Qinhao Wang, Mingyuan Xia, Yi Ru, Wei Hu, Guang Yan, Xin Xiong, Mei Zhang, Jiancai Wang, Qi Li, Bo Zhang, He Wang, Wei Lin, Guojun Wu and Xia Li
      Cancer Biology & Medicine June 2022, 19 (6) 818-835; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0296

  4. Xu, Hui

    1. EHMT2 (G9a) activation in mantle cell lymphoma and its associated DNA methylation and gene expression
      Jun Wang, Hui Xu, Shuang Ge, Chaoshuai Xue, Hailing Li, Xiaotong Jing, Ke Liang, Xiaoying Zhang and Cuijuan Zhang
      Cancer Biology & Medicine June 2022, 19 (6) 836-849; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0371

  5. Xue, Chaoshuai

    1. EHMT2 (G9a) activation in mantle cell lymphoma and its associated DNA methylation and gene expression
      Jun Wang, Hui Xu, Shuang Ge, Chaoshuai Xue, Hailing Li, Xiaotong Jing, Ke Liang, Xiaoying Zhang and Cuijuan Zhang
      Cancer Biology & Medicine June 2022, 19 (6) 836-849; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0371

Y

  1. Yan, Fengqi

    1. MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis
      Fengqi Yan, Qinhao Wang, Mingyuan Xia, Yi Ru, Wei Hu, Guang Yan, Xin Xiong, Mei Zhang, Jiancai Wang, Qi Li, Bo Zhang, He Wang, Wei Lin, Guojun Wu and Xia Li
      Cancer Biology & Medicine June 2022, 19 (6) 818-835; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0296

  2. Yan, Guang

    1. MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis
      Fengqi Yan, Qinhao Wang, Mingyuan Xia, Yi Ru, Wei Hu, Guang Yan, Xin Xiong, Mei Zhang, Jiancai Wang, Qi Li, Bo Zhang, He Wang, Wei Lin, Guojun Wu and Xia Li
      Cancer Biology & Medicine June 2022, 19 (6) 818-835; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0296

  3. Yan, Tao

    1. The advanced development of molecular targeted therapy for hepatocellular carcinoma
      Tao Yan, Lingxiang Yu, Ning Zhang, Caiyun Peng, Guodong Su, Yi Jing, Linzhi Zhang, Tong Wu, Jiamin Cheng, Qian Guo, Xiaoliang Shi and Yinying Lu
      Cancer Biology & Medicine June 2022, 19 (6) 802-817; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0661

  4. Yang, Jianliang

    1. Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP
      Yan Qin, Haizhu Chen, Peng Liu, Changgong Zhang, Jianliang Yang, Lin Gui, Xiaohui He, Liqiang Zhou, Shengyu Zhou, Shiyu Jiang, Hongxin Jiang and Yuankai Shi
      Cancer Biology & Medicine June 2022, 19 (6) 893-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0193

  5. Yang, Jilong

    1. The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
      Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent and Jilong Yang
      Cancer Biology & Medicine June 2022, 19 (6) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0270

  6. Yang, Yun

    1. The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
      Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent and Jilong Yang
      Cancer Biology & Medicine June 2022, 19 (6) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0270

  7. Ye, Yingnan

    1. The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families
      Li Dong, Hailian Zhang, Huan Zhang, Yingnan Ye, Yanan Cheng, Lijuan Li, Lijuan Wei, Lei Han, Yandong Cao, Shixia Li, Xishan Hao, Juntian Liu and Jinpu Yu
      Cancer Biology & Medicine June 2022, 19 (6) 850-870; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0011

  8. Yin, Qiang

    1. Microsurgery vs. radiosurgery for the treatment of multiple metastases in the brain: a retrospective cohort study
      Qun Liu, Qiang Yin, Yang Dong, Fengtong Li, Wenliang Li and Xiaoguang Wang
      Cancer Biology & Medicine June 2022, 19 (6) 884-892; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0598

  9. Yin, Shuangshuang

    1. Anti-tumor pharmacology of natural products targeting mitosis
      Manru Huang, Caiyan Liu, Yingying Shao, Shiyue Zhou, Gaoyong Hu, Shuangshuang Yin, Weiling Pu and Haiyang Yu
      Cancer Biology & Medicine June 2022, 19 (6) 774-801; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0006

  10. Yu, Haiyang

    1. Anti-tumor pharmacology of natural products targeting mitosis
      Manru Huang, Caiyan Liu, Yingying Shao, Shiyue Zhou, Gaoyong Hu, Shuangshuang Yin, Weiling Pu and Haiyang Yu
      Cancer Biology & Medicine June 2022, 19 (6) 774-801; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0006

  11. Yu, Hui

    1. The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
      Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent and Jilong Yang
      Cancer Biology & Medicine June 2022, 19 (6) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0270

  12. Yu, Jinpu

    1. The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families
      Li Dong, Hailian Zhang, Huan Zhang, Yingnan Ye, Yanan Cheng, Lijuan Li, Lijuan Wei, Lei Han, Yandong Cao, Shixia Li, Xishan Hao, Juntian Liu and Jinpu Yu
      Cancer Biology & Medicine June 2022, 19 (6) 850-870; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0011

  13. Yu, Lingxiang

    1. The advanced development of molecular targeted therapy for hepatocellular carcinoma
      Tao Yan, Lingxiang Yu, Ning Zhang, Caiyun Peng, Guodong Su, Yi Jing, Linzhi Zhang, Tong Wu, Jiamin Cheng, Qian Guo, Xiaoliang Shi and Yinying Lu
      Cancer Biology & Medicine June 2022, 19 (6) 802-817; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0661

Z

  1. Zhang, Bo

    1. MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis
      Fengqi Yan, Qinhao Wang, Mingyuan Xia, Yi Ru, Wei Hu, Guang Yan, Xin Xiong, Mei Zhang, Jiancai Wang, Qi Li, Bo Zhang, He Wang, Wei Lin, Guojun Wu and Xia Li
      Cancer Biology & Medicine June 2022, 19 (6) 818-835; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0296

  2. Zhang, Changgong

    1. Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP
      Yan Qin, Haizhu Chen, Peng Liu, Changgong Zhang, Jianliang Yang, Lin Gui, Xiaohui He, Liqiang Zhou, Shengyu Zhou, Shiyu Jiang, Hongxin Jiang and Yuankai Shi
      Cancer Biology & Medicine June 2022, 19 (6) 893-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0193

  3. Zhang, Chunli

    1. Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China
      Chunli Zhang, Wei Wan, Shuai Zhang, Jingwen Wang, Ru Feng, Jiangtao Li, Junyue Chai, Hebing Zhou, Liru Wang, Yuping Zhong, Xiaodong Mo, Mengzhu Shen, Hongmei Jing and Hui Liu
      Cancer Biology & Medicine June 2022, 19 (6) 871-883; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0474

  4. Zhang, Cuijuan

    1. EHMT2 (G9a) activation in mantle cell lymphoma and its associated DNA methylation and gene expression
      Jun Wang, Hui Xu, Shuang Ge, Chaoshuai Xue, Hailing Li, Xiaotong Jing, Ke Liang, Xiaoying Zhang and Cuijuan Zhang
      Cancer Biology & Medicine June 2022, 19 (6) 836-849; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0371

  5. Zhang, Hailian

    1. The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families
      Li Dong, Hailian Zhang, Huan Zhang, Yingnan Ye, Yanan Cheng, Lijuan Li, Lijuan Wei, Lei Han, Yandong Cao, Shixia Li, Xishan Hao, Juntian Liu and Jinpu Yu
      Cancer Biology & Medicine June 2022, 19 (6) 850-870; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0011

  6. Zhang, Huan

    1. The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families
      Li Dong, Hailian Zhang, Huan Zhang, Yingnan Ye, Yanan Cheng, Lijuan Li, Lijuan Wei, Lei Han, Yandong Cao, Shixia Li, Xishan Hao, Juntian Liu and Jinpu Yu
      Cancer Biology & Medicine June 2022, 19 (6) 850-870; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0011

  7. Zhang, Linzhi

    1. The advanced development of molecular targeted therapy for hepatocellular carcinoma
      Tao Yan, Lingxiang Yu, Ning Zhang, Caiyun Peng, Guodong Su, Yi Jing, Linzhi Zhang, Tong Wu, Jiamin Cheng, Qian Guo, Xiaoliang Shi and Yinying Lu
      Cancer Biology & Medicine June 2022, 19 (6) 802-817; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0661

  8. Zhang, Mei

    1. MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis
      Fengqi Yan, Qinhao Wang, Mingyuan Xia, Yi Ru, Wei Hu, Guang Yan, Xin Xiong, Mei Zhang, Jiancai Wang, Qi Li, Bo Zhang, He Wang, Wei Lin, Guojun Wu and Xia Li
      Cancer Biology & Medicine June 2022, 19 (6) 818-835; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0296

  9. Zhang, Ning

    1. The advanced development of molecular targeted therapy for hepatocellular carcinoma
      Tao Yan, Lingxiang Yu, Ning Zhang, Caiyun Peng, Guodong Su, Yi Jing, Linzhi Zhang, Tong Wu, Jiamin Cheng, Qian Guo, Xiaoliang Shi and Yinying Lu
      Cancer Biology & Medicine June 2022, 19 (6) 802-817; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0661

  10. Zhang, Shuai

    1. Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China
      Chunli Zhang, Wei Wan, Shuai Zhang, Jingwen Wang, Ru Feng, Jiangtao Li, Junyue Chai, Hebing Zhou, Liru Wang, Yuping Zhong, Xiaodong Mo, Mengzhu Shen, Hongmei Jing and Hui Liu
      Cancer Biology & Medicine June 2022, 19 (6) 871-883; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0474

  11. Zhang, Xiaoying

    1. EHMT2 (G9a) activation in mantle cell lymphoma and its associated DNA methylation and gene expression
      Jun Wang, Hui Xu, Shuang Ge, Chaoshuai Xue, Hailing Li, Xiaotong Jing, Ke Liang, Xiaoying Zhang and Cuijuan Zhang
      Cancer Biology & Medicine June 2022, 19 (6) 836-849; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0371

  12. Zhao, Jun

    1. The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
      Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent and Jilong Yang
      Cancer Biology & Medicine June 2022, 19 (6) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0270

  13. Zhao, Yongtian

    1. The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
      Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent and Jilong Yang
      Cancer Biology & Medicine June 2022, 19 (6) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0270

  14. Zhong, Yuping

    1. Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China
      Chunli Zhang, Wei Wan, Shuai Zhang, Jingwen Wang, Ru Feng, Jiangtao Li, Junyue Chai, Hebing Zhou, Liru Wang, Yuping Zhong, Xiaodong Mo, Mengzhu Shen, Hongmei Jing and Hui Liu
      Cancer Biology & Medicine June 2022, 19 (6) 871-883; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0474

  15. Zhou, Hebing

    1. Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China
      Chunli Zhang, Wei Wan, Shuai Zhang, Jingwen Wang, Ru Feng, Jiangtao Li, Junyue Chai, Hebing Zhou, Liru Wang, Yuping Zhong, Xiaodong Mo, Mengzhu Shen, Hongmei Jing and Hui Liu
      Cancer Biology & Medicine June 2022, 19 (6) 871-883; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0474

  16. Zhou, Liqiang

    1. Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP
      Yan Qin, Haizhu Chen, Peng Liu, Changgong Zhang, Jianliang Yang, Lin Gui, Xiaohui He, Liqiang Zhou, Shengyu Zhou, Shiyu Jiang, Hongxin Jiang and Yuankai Shi
      Cancer Biology & Medicine June 2022, 19 (6) 893-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0193

  17. Zhou, Shengyu

    1. Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP
      Yan Qin, Haizhu Chen, Peng Liu, Changgong Zhang, Jianliang Yang, Lin Gui, Xiaohui He, Liqiang Zhou, Shengyu Zhou, Shiyu Jiang, Hongxin Jiang and Yuankai Shi
      Cancer Biology & Medicine June 2022, 19 (6) 893-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0193

  18. Zhou, Shiyue

    1. Anti-tumor pharmacology of natural products targeting mitosis
      Manru Huang, Caiyan Liu, Yingying Shao, Shiyue Zhou, Gaoyong Hu, Shuangshuang Yin, Weiling Pu and Haiyang Yu
      Cancer Biology & Medicine June 2022, 19 (6) 774-801; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0006
Back to top

In this issue

Cancer Biology & Medicine: 19 (6)
Cancer Biology & Medicine
Vol. 19, Issue 6
15 Jun 2022

Submit

Sign up for alerts